Purpose
To expand sustainable vaccine manufacturing by supporting Biovac’s ability to produce, scale, and supply affordable RNA vaccines that address priority public health needs in low- and middle-income countries.
Grantee
Division
Global Health
Date
NOVEMBER 2025
Region served
GLOBAL
Committed amount
$2,007,745
Grant topic
Vaccine Development
Duration (months)
18
Grantee location
Cape Town, Western Cape, South Africa
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.